Parenteral Nutrition Market to Reach USD 13.4 Billion by 2035 as Clinical Nutrition Trends Drive Industry Growth

The global parenteral nutrition market was valued at USD 7.2 billion in 2024 and is projected to reach USD 13.4 billion by 2035, growing at a CAGR of 5.8% from 2025 to 2035. Market growth is driven by the rising prevalence of chronic diseases, increasing demand for clinical nutrition support, and advancements in hospital and home healthcare services.

The parenteral nutrition industry is fueled by several key drivers, including the growing prevalence of chronic diseases, hospitalization, and advancements in medical technology. Due to growing incidences of gastrointestinal disease, neurological disease, and cancer, the market for specialized nutrition has accelerated.

Review significant findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611

Additionally, the parenteral nutrition market is fueled by the increasing geriatric population worldwide, which demonstrates the demand for long-term nutritional treatments. Advancements in parenteral nutrition products and delivery systems improve patient safety and outcomes, thereby making the products even more appealing to healthcare professionals.

Another prominent factor contributing to the growth of the parenteral nutrition market is the shift toward home-based and outpatient healthcare solutions. As more attention is paid to lowering hospitalization and healthcare expenses, parenteral nutrition is optimized for home administration. In addition, enhanced awareness among healthcare professionals regarding the advantages of customized parenteral nutrition products has spurred adoption. These are complemented by favorable government policies and clinical guidelines facilitating the application of specialized nutrition therapies to maximize patient recovery and health.

Market Overview

Parenteral nutrition implies a specialized medical intervention used for delivering the essential nutrients into the bloodstream on a direct basis via intravenous infusion, thereby bypassing the digestive system. The method is employed along with peripheral and/or central venous catheters for patients battling enteral and oral refractory malnutrition owing to intestinal failure, postoperative conditions, or acute gastrointestinal diseases, thereby making it a primary choice for nutrition support. In addition to macronutrients like carbohydrates, fats, and proteins, parenteral nutrition also provides micronutrients like vitamins, trace elements, and electrolytes, which are vital for maintenance of metabolic functions and facilitate recovery.

The formulation of parenteral nutrition is meticulously individualized to a single patient's requirements in order to meet appropriate nutrient distribution. Patients may receive total parenteral nutrition (TPN), whereby all the nutritional needs are met intravenously, or partial parenteral nutrition (PPN), which is considered as one of the supplements to enteral or oral alimentation.

Key Market Growth Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of inflammatory bowel disease (IBD), short bowel syndrome, intestinal failure, Crohn's disease, and gastrointestinal cancers is significantly driving demand for parenteral nutrition therapies.

Patients with impaired digestive function increasingly rely on intravenous nutritional support.

Growing Number of Preterm Births

The rising number of premature births worldwide is boosting the demand for neonatal parenteral nutrition to support infant growth and development during critical care.

Hospitals continue to adopt specialized neonatal nutrition protocols to improve survival outcomes.

Increasing Burden of Chronic Diseases

Growing cases of cancer, neurological disorders, metabolic diseases, and critical illnesses requiring intensive care are expanding the use of parenteral nutrition in hospitals and long-term care facilities.

Advancements in Clinical Nutrition

Innovations in ready-to-use multi-chamber bags, customized formulations, lipid emulsions, and infusion technologies are improving treatment efficiency, reducing preparation errors, and enhancing patient safety.

Analysis of Key Players

The parenteral nutrition market is highly competitive, with leading pharmaceutical and medical nutrition companies focusing on product innovation, manufacturing expansion, and strategic collaborations.

• Baxter
• B. Braun SE
• Fresenius Kabi AG
• Pfizer Inc.
• Grifols, S.A.
• Otsuka Pharmaceutical Factory, Inc.
• Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd
• ICU Medical, Inc.
• Otsuka Holdings Co., Ltd.
• Aculife
• SGD Pharma
• Optum, Inc.
• Torbay Pharma
• KENHEAL HEALTHCARE PVT LTD
• Option Care Health Inc.

Recent industry developments include the launch of advanced multi-chamber nutrition bags, enhanced lipid emulsion formulations, expansion of sterile manufacturing facilities, and increased investments in home parenteral nutrition solutions.

Key Player Strategies

Leading companies are implementing several strategic initiatives to strengthen market competitiveness:

• Development of ready-to-use multi-chamber parenteral nutrition formulations
• Investment in personalized clinical nutrition solutions
• Expansion of sterile manufacturing and filling facilities
• Strategic collaborations with hospitals and healthcare providers
• Continuous research and development in advanced nutritional formulations
• Geographic expansion into emerging healthcare markets
• Enhancement of product safety and shelf life
• Adoption of automated compounding technologies
• Strengthening regulatory compliance and quality assurance
• Expansion of home healthcare nutrition support services

These strategies are enabling manufacturers to improve patient care while meeting the growing global demand for intravenous nutritional support.

Market Challenges & Opportunities

Challenges

Despite favorable growth prospects, the market faces challenges including high treatment costs, risks associated with catheter-related infections, stringent regulatory requirements, and limited availability of specialized healthcare professionals.

Manufacturers must also ensure uninterrupted supply of sterile formulations while maintaining high quality and safety standards.

Opportunities

Growing investments in neonatal intensive care, oncology nutrition, home healthcare, personalized medicine, and hospital infrastructure present significant opportunities for market participants.

The expansion of home parenteral nutrition programs, advanced infusion technologies, AI-assisted nutrition management, and emerging healthcare markets is expected to create additional growth opportunities.

Increasing awareness regarding clinical nutrition and improved patient management protocols will further strengthen long-term market expansion.

Investment Landscape and ROI Outlook

The Parenteral Nutrition Market continues to attract investments from pharmaceutical companies, medical nutrition manufacturers, hospitals, healthcare providers, and institutional investors.

Investment is increasingly directed toward sterile production facilities, innovative nutritional formulations, automated compounding systems, and home infusion technologies.

As demand for specialized nutritional support continues to rise globally, the market is expected to generate stable long-term returns on investment through 2035.

The combination of increasing chronic disease prevalence, growing neonatal care requirements, expanding healthcare infrastructure, and continuous innovation positions the parenteral nutrition market as a vital segment within the global clinical nutrition industry.

Market Segmentation

Nutrition Type

• Total Parenteral Nutrition (TPN)
• Partial Parenteral Nutrition (PPN)

Composition

• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

Patient Age Group

• Pediatric
• Adult
• Geriatric

Indication

• Neurodegenerative Disorders
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Dysphagia
• Pain Management
• Others (GI Disorder, etc.)

End-user

• Hospitals and Ambulatory Surgical Centers
• Long-term Care Facilities
• Outpatient Clinics
• Others (Homecare Setting, etc.)

Why Buy This Report?

• Gain comprehensive insights into current and future parenteral nutrition market trends
• Access detailed market size estimates and forecasts through 2035
• Understand key growth drivers, challenges, and emerging opportunities
• Evaluate competitive positioning of leading clinical nutrition manufacturers
• Analyze advancements in multi-chamber bags, infusion technologies, and personalized nutrition solutions
• Assess regional and segment-level market dynamics
• Identify high-growth investment opportunities across the clinical nutrition value chain
• Track recent product launches, partnerships, acquisitions, and technological innovations
• Support strategic business planning and investment decisions
• Obtain actionable market intelligence to strengthen competitive positioning

Buy this Premium Research Report to gain valuable industry intelligence – https://www.transparencymarketresearch.com/checkout.php?rep_id=3611<ype=S

Frequently Asked Questions

·        How big was the global parenteral nutrition market in 2024?

The global parenteral nutrition market was valued at US$ 7.2 Bn in 2024

·        How big will the global parenteral nutrition industry be in 2035?

The global parenteral nutrition industry is projected to reach more than US$ 13.4 Bn by the end of 2035

·        What are the factors driving the parenteral nutrition market?

The increasing global prevalence of chronic diseases, a growing elderly population susceptible to malnutrition, advancements in home parenteral nutrition, and the rising number of complex surgeries are among the factors driving the expansion of the parenteral nutrition market.

·        What will be the CAGR of the global parenteral nutrition industry during the forecast period?

The CAGR is anticipated to be 5.8% from 2025 to 2035

Explore Latest Research Reports by Transparency Market Research:

South America Equine Supplement Market

Fish Collagen Peptides Market

Collagen Peptide And Gelatin Market

Africa Liposomal Vitamins and Minerals Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com  

Media Inquiries: media@transparencymarketresearch.com